Home › Research › Cognitive tests and assessment
Delusions and hallucinations are associated with worse outcome in Alzheimer disease
Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D et al.. Archives of neurology, 2005-10-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Delusions and hallucinations are common in Alzheimer disease (AD) and there are conflicting reports regarding their ability to predict cognitive decline, functional decline, and institutionalization. According to all previous literature, they are not associated with mortality. Objective To examine whether the presence of delusions or hallucinations has predictive value for important outcomes in AD.
What this study adds
Evidence grade: Moderate
The record lists 456 participants. In 456 patients with early Alzheimer disease followed for up to 14 years, delusions and hallucinations were examined for their ability to predict outcomes such as cognitive decline, functional decline and institutionalization. This is about predicting how the disease progresses, not about treating, curing or preventing it.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Scarmeas, N., Brandt, J., Albert, M., Hadjigeorgiou, G., Papadimitriou, A., Dubois, B., et al. (2005). Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of neurology. https://doi.org/10.1001/archneur.62.10.1601
Vancouver
Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of neurology. 2005. doi:10.1001/archneur.62.10.1601. PMID: 16216946.
BibTeX
@article{scarmeas2005-16216946,
author = {Scarmeas, N. and Brandt, J. and Albert, M. and Hadjigeorgiou, G. and Papadimitriou, A. and Dubois, B. and Sarazin, M. and Devanand, D. and others},
title = {{Delusions and hallucinations are associated with worse outcome in Alzheimer disease}},
journal = {Archives of neurology},
year = {2005},
doi = {10.1001/archneur.62.10.1601},
pmid = {16216946},
url = {https://doi.org/10.1001/archneur.62.10.1601}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- According to all previous literature, they are not associated with mortality.
- Objective To examine whether the presence of delusions or hallucinations has predictive value for important outcomes in AD.
- Design, setting, and participants A total of 456 patients with AD at early stages (mean Folstein Mini-Mental State Examination [MMSE] score of 21 of 30 at entry) were recruited and followed up semiannually for up to 14 years (mean, 4.5 years) in 5 university-based AD centers in the United States and Europe.
- Using the Columbia University Scale for Psychopathology in AD (administered every 6 months, for a total of 3266 visit-assessments, average of 7.2 per patient), the presence of delusions and hallucinations was extracted and examined as time-dependent predictors in Cox models.
Why it matters
In 456 patients with early Alzheimer disease followed for up to 14 years, delusions and hallucinations were examined for their ability to predict outcomes such as cognitive decline, functional decline and institutionalization. This is about predicting how the disease progresses, not about treating, curing or preventing it.
Study details
- Participants456
- Evidence strengthModerate
How this study scored 56/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | 3 / 4 | Archives of Neurology: journal h-index 353 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2005 — older than 20 years, still counted |
| Sample size | 2 / 4 | 456 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 355 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 15.4 citations a year over 23 year(s) since 2005 |
| Impact for its field and year | 3 / 6 | Cited 6.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 10 other studies in this library |
| Still being cited | 2 / 4 | Cited 37 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Yaakov Stern: h-index 162 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Columbia University: institution h-index 1,824 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | PubMed indexes it as a multicentre study |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 16216946) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 56 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/archneur.62.10.1601
- PubMed: 16216946
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
10 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Cognitive tests and assessment from nearby years
Also in Cognitive tests and assessment
99 studies in the library are filed under Cognitive tests and assessment with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Cognitive tests and assessment hub.